CORONA Remedies Limited (NSE:CORONA)
India flag India · Delayed Price · Currency is INR
1,388.30
-70.50 (-4.83%)
At close: Jan 21, 2026

CORONA Remedies Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Debt / Equity Ratio
0.100.140.330.070.140.18
Debt / EBITDA Ratio
0.230.361.020.222.620.58
Debt / FCF Ratio
0.540.87-3.520.731.76
Asset Turnover
-1.361.421.601.18-
Inventory Turnover
-2.132.292.402.86-
Quick Ratio
0.880.510.470.780.602.08
Current Ratio
1.431.411.292.121.922.42
Return on Equity (ROE)
-27.50%20.36%23.29%-0.12%-
Return on Assets (ROA)
-14.45%11.21%12.19%-0.31%-
Return on Invested Capital (ROIC)
26.06%23.15%18.58%21.48%-0.76%20.77%
Return on Capital Employed (ROCE)
32.00%29.50%21.10%23.60%-0.70%22.50%
Payout Ratio
25.54%15.14%18.72%8.21%--
Buyback Yield / Dilution
0.04%--4.89%-14.21%16.53%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.